There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...
The "miracle tool" HIV medicine lenacapavir will be sold in South Africa from as early as March or April 2026 according to ...
Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...
The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in ...
A Mumbai clinic celebrated 25 years of survival for an HIV patient once near death. Diagnosed with PML and a CD4 count of 12 ...
The US Department of State has announced a life-saving development to bring US-based Gilead Sciences’ breakthrough drug lenacapavir to market in Uganda, one of just ten high-burden HIV/Aids countries ...
Len is for HIV-negative people to try and stop them from getting HIV…when you get an injection, the contents of the injection ...
The NIH funding will help address a "traditional barrier" to health care, says Elizabeth Evans, professor of community health ...
Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback